Finance / Biotech Stocks

Recursion Pharmaceuticals Begins Dosing in Early-Stage B-Cell Lymphoma Study

Recursion Pharmaceuticals (often associated with the ticker RXRX) has announced a significant step in its clinical development pipeline: the first patient has been dosed in its early-stage clinical trial targeting B-cell lymphomas. This mil...